FPFS
ALDR

First Personal Financial Services’s Alder Biopharmaceuticals ALDR Stock Holding History

First Personal Financial Services’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-771
Closed -$10K – 1019
2018
Q1 		$10K Sell
771
-520
-40% -$7.52K ﹤0.01% 795
2017
Q4 		$15K Hold
1,291
– – ﹤0.01% 710
2017
Q3 		$16K Buy
+1,291
New +$13.5K ﹤0.01% 629

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Personal Financial Services's ALDR Position: Q2 2018 in Review

First Personal Financial Services sold out of Alder Biopharmaceuticals (ALDR) in Q2 2018, closing a stake of 771 shares — an estimated $10K sold.

First Personal Financial Services first reported a position in ALDR in Q3 2017 and held it in 3 quarters. The position peaked at $16K in Q3 2017. 139 funds tracked by Wall St. Rank hold ALDR as of Q2 2018.

  • First Personal Financial Services reported no remaining Alder Biopharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • First Personal Financial Services sold 771 Alder Biopharmaceuticals shares in Q2 2018, an estimated $10K.
  • First Personal Financial Services first reported a position in Alder Biopharmaceuticals in Q3 2017 and held it in 3 quarters.
  • First Personal Financial Services's Alder Biopharmaceuticals position peaked at $16K in Q3 2017.
  • 139 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2018.

Based on First Personal Financial Services's 13F filing for Q2 2018, filed 7 Aug 2018.